Invisioner,

We, as investors and potential patients, are lucky for the impending impact of leronlimab.

My feeling is that the role that inflammation plays in many, if not most chronic disease, is still under appreciated in the medical community.

It really upends a lot of medicine. As Carl Sagan noted, “ Extraordinary claims require extraordinary evidence.”

The evidence, IMO, is undeniable despite its slow acknowledgment and acceptance.

We’re getting there.